BioInsights - Roundtable Roundup: strategies for scaling up and out in gene therapy manufacturing - addressing AAV’s growing pains

Roundtable Roundup: strategies for scaling up and out in gene therapy manufacturing - addressing AAV’s growing pains

Cell & Gene Therapy Insights 2022;8(2), 341

10.18609/cgti.2022.051

Published: 22 March 2022
Christopher Reardon, Phillip Vermilion, John Yoshi Shyu

In a recent Expert Roundtable discussion, we spoke to three experts about the challenges the rapidly expanding gene therapy field is facing in scaling up adeno-associated vector manufacturing, and the potential solutions. Here, we sum up some of their key thoughts.